|Articles|February 10, 2023
SCOPE 2023: Primary Clinical Trial Concerns
Author(s)Andy Studna, Senior Editor
Murray L. Aitken, SVP of IQVIA speaks about the concerns of smaller biopharma companies getting into clinical trials at the SCOPE 2023 conference in Orlando, FL.
Advertisement
In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Murray L. Aitken, SVP of IQVIA discusses the concerns of smaller biopharma companies getting into clinical trials.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
Q&A: Strategies for Successful Global Clinical Trial DeliverySeptember 12th 2025
eClinical Technology: Misconceptions, Challenges, and OpportunitiesSeptember 9th 2025
How Sponsors Can Modernize Tools to Support PhysiciansSeptember 9th 2025
Why Decentralized Trials Face Slow Adoption Despite Strong DataAugust 26th 2025
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
